Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,622 papers from all fields of science
Search
Sign In
Create Free Account
tertatolol
Known as:
1-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)-2-propanol
, 2-propanol, 1-((3,40dihydro-2H-1-benzothiopyran-8-yl)oxy)-3-((1,1-dimethylethyl)amino)-
, Racemic Teraterol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (4)
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Propanolamines
Thiophenes
Narrower (2)
Artex
S 2395
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Mechanism of action of flibanserin in the learned helplessness paradigm in rats.
F. Borsini
,
R. Cesana
European Journal of Pharmacology
2001
Corpus ID: 43801877
1999
1999
Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat
C. Becker
,
M. Hamon
,
J. Benoliel
Neuropharmacology
1999
Corpus ID: 28958563
1994
1994
Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors
H. Francès
,
C. Monier
,
M. Debray
Pharmacology, Biochemistry and Behavior
1994
Corpus ID: 10089774
1993
1993
(−)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain
T. Jolas
,
S. Haj-Dahmane
,
+6 authors
M. Hamon
Naunyn-Schmiedeberg's Archives of Pharmacology
1993
Corpus ID: 22129922
SummaryThe potential 5-HT1A antagonist properties of the ß-antagonist tertatolol were assessed using biochemical and…
Expand
1991
1991
Localization and characterization of two propranolol resistant (-) [125I]cyanopindolol binding sites in rat skeletal muscle.
P. Molenaar
,
S. Roberts
,
Y. S. Kim
,
H. S. Pak
,
R. Sainz
,
R. Summers
European Journal of Pharmacology
1991
Corpus ID: 4524038
1988
1988
Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
A. de Blasi
,
M. Fratelli
,
O. Marasco
Circulation Research
1988
Corpus ID: 44262967
We have previously reported that a potent new beta-blocker, tertatolol, when given at therapeutic doses to healthy volunteers…
Expand
1986
1986
Reduction of beta‐adrenergic receptors by tertatolol: An additional mechanism for beta‐adrenergic blockade
A. Blasi
,
M. Lipartiti
,
C. Rochat
,
J. Prost
,
S. Garattini
Clinical pharmacology and therapy
1986
Corpus ID: 25501851
Tertatolol is a potent new β‐blocker with no intrinsic sympathomimetic activity or β1/β2‐receptor subtype selectivity. When given…
Expand
1986
1986
Renal hemodynamic effects of tertatolol in essential hypertension.
F. Paillard
,
B. Lantz
,
F. Leviel
,
R. Ardaillou
American Journal of Nephrology
1986
Corpus ID: 46800564
Tertatolol, a new beta-blocker, and propranolol, considered a reference beta-blocker, were given orally (5 and 160 mg slow…
Expand
Review
1986
Review
1986
Biodisposition of tertatolol in man: a review.
D. Campbell
,
J. Chignon
,
J. Devissaguet
American Journal of Nephrology
1986
Corpus ID: 3269337
Tertatolol is rapidly (tmax: 1.25 h) and totally absorbed by the gastro-intestinal tract with a low presystemic metabolism, and…
Expand
1985
1985
Central and peripheral sites for cardiovascular actions of dynorphin-(1-13) in rats.
B. Gautret
,
H. Schmitt
European Journal of Pharmacology
1985
Corpus ID: 37460561
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE